X 
Financials Ratios
Home | Market Info | Company Profile | Financials Ratios
Vanta Bioscience Ltd.
BSE CODE: 540729   |   NSE CODE: NA   |   ISIN CODE : INE695X01011   |   31-Dec-2025 16:01 Hrs IST
BSE NSE
Rs. 23.50
0.9 ( 3.98% )
 
Prev Close ( Rs.)
22.60
Open ( Rs.)
20.60
 
High ( Rs.)
23.50
Low ( Rs.)
20.60
 
Volume
6000
Week Avg.Volume
NA
 
52 WK High-Low Range(Rs.)
BSE NSE
Rs.
( )
 
Prev Close ( Rs.)
Open ( Rs.)
 
High ( Rs.)
Low ( Rs.)
 
Volume
Week Avg.Volume
NA
 
52 WK High-Low Range(Rs.)
Particulars Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021
Operational & Financial Ratios          
   Earnings Per Share (Rs)-4.21  0.08  -6.71  0.12  0.75  
   CEPS(Rs)-3.52  2.04  -4.73  2.21  2.73  
   DPS(Rs)0.00  0.00  0.00  0.00  0.00  
   Book NAV/Share(Rs)27.14  31.36  31.28  38.01  37.88  
   Tax Rate(%)2.19  -22.44  -0.67  43.78  22.27  
Margin Ratios          
   Core EBITDA Margin(%)-146.85  42.68  -9.20  36.38  38.79  
   EBIT Margin(%)-182.41  28.79  -21.28  24.10  26.53  
   Pre Tax Margin(%)-241.17  0.49  -81.36  1.49  6.03  
   PAT Margin (%)-235.88  0.60  -81.91  0.84  4.68  
   Cash Profit Margin (%)-196.85  15.04  -57.73  14.92  17.15  
Performance Ratios          
   ROA(%)-4.89  0.10  -8.30  0.16  1.07  
   ROE(%)-14.40  0.26  -19.37  0.33  1.99  
   ROCE(%)-4.43  5.43  -2.44  5.24  6.76  
   Asset Turnover(x)0.02  0.16  0.10  0.19  0.23  
   Sales/Fixed Asset(x)0.02  0.19  0.12  0.25  0.36  
   Working Capital/Sales(x)-0.14  -3.93  5.84  9.17  3.77  
Efficiency Ratios          
   Fixed Capital/Sales(x)42.78  5.20  8.20  3.97  2.81  
   Receivable days660.77  90.86  93.40  52.75  60.64  
   Inventory Days2260.96  312.25  507.98  331.82  432.17  
   Payable days844.17  3147.02  1023.32  565.86  213.02  
Valuation Parameters          
   PER(x)0.00  791.10  0.00  883.04  218.76  
   PCE(x)-6.29  31.39  -12.16  49.72  59.76  
   Price/Book(x)0.81  2.04  1.84  2.89  4.30  
   Yield(%)0.00  0.00  0.00  0.00  0.00  
   EV/Net Sales(x)39.29  7.67  11.99  9.63  12.24  
   EV/Core EBITDA(x)-27.40  17.74  413.82  25.22  30.68  
   EV/EBIT(x)-21.54  26.64  -56.32  39.96  45.09  
   EV/CE(x)0.93  1.45  1.36  1.78  2.59  
   M Cap / Sales12.38  4.72  7.02  7.42  10.48  
Growth Ratio          
   Net Sales Growth(%)-86.83  65.50  -44.69  -4.74  -28.48  
   Core EBITDA Growth(%)-143.69  2370.04  -95.80  -8.83  -11.53  
   EBIT Growth(%)-183.46  323.89  -148.84  -15.40  -17.70  
   PAT Growth(%)-5309.21  101.21  -5495.52  -83.31  -51.91  
   EPS Growth(%)-5308.03  101.21  -5494.05  -83.30  -51.91  
Financial Stability Ratios          
   Total Debt/Equity(x)1.78  1.28  1.30  0.87  0.72  
   Current Ratio(x)0.56  0.85  1.09  1.10  1.24  
   Quick Ratio(x)0.21  0.32  0.39  0.38  0.35  
   Interest Cover(x)-3.10  1.02  -0.35  1.07  1.29  
   Total Debt/Mcap(x)2.18  0.63  0.71  0.30  0.17